Immunohistochemical Determination of Vascular Endothelial Growth Factor (VEGF) Overexpression in Malignant Melanoma

Anil Potti, Nauman Moazzam, Ketki Tendulkar, Nazia Ali Javed, Michael Koch, Steve Kargas

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Background: Molecular changes associated with the transition of melanoma cells from radial to vertical growth phase are not defined. To evaluate the role of VEGF in melanogenesis and determine its possible diagnostic and prognostic implications, we analyzed overexpression of VEGF in 202 cases of melanoma. Materials and Methods: Overexpression of VEGF was evaluated in 202 archival paraffin-embedded tissue specimens using an avidin-biotin immunohistochemical (IHC) assay. Results: Of the 202 melanoma specimens, 42 (20.8%) showed evidence of VEGF overexpression on IHC testing. Multivariate analysis performed using Cox proportional hazards method did not show a statistically significant survival difference between the VEGF-positive and negative groups (p=0.25). Conclusion: Although of no significant prognostic value, VEGF may have critical therapeutic implications as a molecular target since it is expressed in about 20% of melanomas. The role of target-specific therapies against VEGF in malignant melanoma warrants further investigations.

Original languageEnglish (US)
Pages (from-to)4023-4026
Number of pages4
JournalAnticancer Research
Volume23
Issue number5 A
StatePublished - Sep 1 2003

Fingerprint

Vascular Endothelial Growth Factor A
Melanoma
Avidin
Biotin
Paraffin
Multivariate Analysis
Therapeutics
Growth

Keywords

  • Immunohistochemistry
  • Malignant melanoma
  • Overexpression
  • Survival
  • Vascular endothelial growth factor

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Immunohistochemical Determination of Vascular Endothelial Growth Factor (VEGF) Overexpression in Malignant Melanoma. / Potti, Anil; Moazzam, Nauman; Tendulkar, Ketki; Javed, Nazia Ali; Koch, Michael; Kargas, Steve.

In: Anticancer Research, Vol. 23, No. 5 A, 01.09.2003, p. 4023-4026.

Research output: Contribution to journalArticle

Potti, Anil ; Moazzam, Nauman ; Tendulkar, Ketki ; Javed, Nazia Ali ; Koch, Michael ; Kargas, Steve. / Immunohistochemical Determination of Vascular Endothelial Growth Factor (VEGF) Overexpression in Malignant Melanoma. In: Anticancer Research. 2003 ; Vol. 23, No. 5 A. pp. 4023-4026.
@article{35e2a6d2b9da445f8f03e25eb05053a9,
title = "Immunohistochemical Determination of Vascular Endothelial Growth Factor (VEGF) Overexpression in Malignant Melanoma",
abstract = "Background: Molecular changes associated with the transition of melanoma cells from radial to vertical growth phase are not defined. To evaluate the role of VEGF in melanogenesis and determine its possible diagnostic and prognostic implications, we analyzed overexpression of VEGF in 202 cases of melanoma. Materials and Methods: Overexpression of VEGF was evaluated in 202 archival paraffin-embedded tissue specimens using an avidin-biotin immunohistochemical (IHC) assay. Results: Of the 202 melanoma specimens, 42 (20.8{\%}) showed evidence of VEGF overexpression on IHC testing. Multivariate analysis performed using Cox proportional hazards method did not show a statistically significant survival difference between the VEGF-positive and negative groups (p=0.25). Conclusion: Although of no significant prognostic value, VEGF may have critical therapeutic implications as a molecular target since it is expressed in about 20{\%} of melanomas. The role of target-specific therapies against VEGF in malignant melanoma warrants further investigations.",
keywords = "Immunohistochemistry, Malignant melanoma, Overexpression, Survival, Vascular endothelial growth factor",
author = "Anil Potti and Nauman Moazzam and Ketki Tendulkar and Javed, {Nazia Ali} and Michael Koch and Steve Kargas",
year = "2003",
month = "9",
day = "1",
language = "English (US)",
volume = "23",
pages = "4023--4026",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "5 A",

}

TY - JOUR

T1 - Immunohistochemical Determination of Vascular Endothelial Growth Factor (VEGF) Overexpression in Malignant Melanoma

AU - Potti, Anil

AU - Moazzam, Nauman

AU - Tendulkar, Ketki

AU - Javed, Nazia Ali

AU - Koch, Michael

AU - Kargas, Steve

PY - 2003/9/1

Y1 - 2003/9/1

N2 - Background: Molecular changes associated with the transition of melanoma cells from radial to vertical growth phase are not defined. To evaluate the role of VEGF in melanogenesis and determine its possible diagnostic and prognostic implications, we analyzed overexpression of VEGF in 202 cases of melanoma. Materials and Methods: Overexpression of VEGF was evaluated in 202 archival paraffin-embedded tissue specimens using an avidin-biotin immunohistochemical (IHC) assay. Results: Of the 202 melanoma specimens, 42 (20.8%) showed evidence of VEGF overexpression on IHC testing. Multivariate analysis performed using Cox proportional hazards method did not show a statistically significant survival difference between the VEGF-positive and negative groups (p=0.25). Conclusion: Although of no significant prognostic value, VEGF may have critical therapeutic implications as a molecular target since it is expressed in about 20% of melanomas. The role of target-specific therapies against VEGF in malignant melanoma warrants further investigations.

AB - Background: Molecular changes associated with the transition of melanoma cells from radial to vertical growth phase are not defined. To evaluate the role of VEGF in melanogenesis and determine its possible diagnostic and prognostic implications, we analyzed overexpression of VEGF in 202 cases of melanoma. Materials and Methods: Overexpression of VEGF was evaluated in 202 archival paraffin-embedded tissue specimens using an avidin-biotin immunohistochemical (IHC) assay. Results: Of the 202 melanoma specimens, 42 (20.8%) showed evidence of VEGF overexpression on IHC testing. Multivariate analysis performed using Cox proportional hazards method did not show a statistically significant survival difference between the VEGF-positive and negative groups (p=0.25). Conclusion: Although of no significant prognostic value, VEGF may have critical therapeutic implications as a molecular target since it is expressed in about 20% of melanomas. The role of target-specific therapies against VEGF in malignant melanoma warrants further investigations.

KW - Immunohistochemistry

KW - Malignant melanoma

KW - Overexpression

KW - Survival

KW - Vascular endothelial growth factor

UR - http://www.scopus.com/inward/record.url?scp=0345305220&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0345305220&partnerID=8YFLogxK

M3 - Article

C2 - 14666713

AN - SCOPUS:0345305220

VL - 23

SP - 4023

EP - 4026

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 5 A

ER -